Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Virological and Social Outcomes of HIV-Infected Adolescents and Young Adults in The Netherlands Before and After Transition to Adult Care.

Weijsenfeld AM, Smit C, Cohen S, Wit FWNM, Mutschelknauss M, van der Knaap LC, van Zonneveld LM, Zomer BJ, Nauta N, Patist JC, Kuipers-Jansen MHJ, Smit EP, Blokhuis C, Pajkrt D; Dutch HIV Adolescents and Young Adults (AYA) Study Group, Weijsenfeld AM, Cohen S, Blokhuis C, van der Plas A, Scherpbier HJ, Mutschelknauss M, Nellen FJB, Prins JM, Pajkrt D, Smit C, Wit FWNM, Reiss P, van der Knaap L, Visser E, van Zonneveld LM, Vriesde ME, Bassant NY, van der Ende ME, van Rossum AMC, Driessen GJA, Fraaij PLA, Smit JV, Smit EP, Kastelijns MPW, den Hollander JG, Pogány K, Moons C, Kroon FP, Oude Geerdink E, van der Meche IB, Schouten WEM, Brinkman K, Ter Beest G, Gisolf EH, Richter C, Zomer BJ, Strik-Albers R, van der Flier M, Henriet SS, Koopmans PP, Patist JC, Nauta N, Geelen SPM, Wolfs TFW, Hoepelman IM, Mudrikova T, van der Meulen PA, de Jonge H, Scholvink EH, Bierman WFW, van den Berg JF, Bouwhuis JW, Faber S, van Vonderen M, Schippers JA, Lowe SH, Kuipers-Jansen MHJ, van Kasteren MEE, Brouwer AE, Pronk DC, Kortmann W.

Clin Infect Dis. 2016 Oct 15;63(8):1105-1112. doi: 10.1093/cid/ciw487. Epub 2016 Jul 20.

PMID:
27439528
2.

Within-Host and Population Transmission of blaOXA-48 in K. pneumoniae and E. coli.

Haverkate MR, Dautzenberg MJ, Ossewaarde TJ, van der Zee A, den Hollander JG, Troelstra A, Bonten MJ, Bootsma MC.

PLoS One. 2015 Oct 20;10(10):e0140960. doi: 10.1371/journal.pone.0140960. eCollection 2015.

3.

Telaprevir pharmacokinetics in a hepatitis C virus infected patient on haemodialysis.

de Kanter CT, den Hollander JG, Verweij-van Wissen CP, Burger DM.

J Clin Virol. 2014 Aug;60(4):431-2. doi: 10.1016/j.jcv.2014.05.008. Epub 2014 May 29. No abstract available.

PMID:
24929751
4.

A randomized controlled study of accelerated versus standard hepatitis B vaccination in HIV-positive patients.

de Vries-Sluijs TE, Hansen BE, van Doornum GJ, Kauffmann RH, Leyten EM, Mudrikova T, Brinkman K, den Hollander JG, Kroon FP, Janssen HL, van der Ende ME, de Man RA.

J Infect Dis. 2011 Apr 1;203(7):984-91. doi: 10.1093/infdis/jiq137. Epub 2011 Jan 25.

PMID:
21266513
5.

Three diagnoses become one: a woman with ground-glass attenuation develops fever.

Hoorn EJ, van Laar JA, den Hollander JG, Kros JM, Brusse E.

Thorax. 2010 Mar;65(3):214, 270. doi: 10.1136/thx.2009.128397. No abstract available.

PMID:
20335289
6.

Nontuberculous mycobacteria infection and tumor necrosis factor-alpha antagonists.

Swart RM, van Ingen J, van Soolingen D, Slingerland R, Hendriks WD, den Hollander JG.

Emerg Infect Dis. 2009 Oct;15(10):1700-1. doi: 10.3201/eid1510.090110. No abstract available.

7.

Photodynamic therapy with topical metatetrahydroxychlorin (Fosgel) is ineffective for the treatment of anal intraepithelial neoplasia, grade III.

van der Snoek EM, Amelink A, van der Ende ME, den Hollander JC, den Hollander JG, Kroon FP, Vriesendorp R, Neumann HA, Robinson DJ.

J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):141-3. doi: 10.1097/QAI.0b013e3181b05f93. No abstract available.

PMID:
19704267
8.

Hepatotoxicity of oral and intravenous voriconazole in relation to cytochrome P450 polymorphisms.

Levin MD, den Hollander JG, van der Holt B, Rijnders BJ, van Vliet M, Sonneveld P, van Schaik RH.

J Antimicrob Chemother. 2007 Nov;60(5):1104-7. Epub 2007 Sep 7.

PMID:
17827141
9.

An itchy holiday.

van Nispen tot Pannerden C, van Gompel F, Rijnders BJ, Caumes E, den Hollander JG.

Neth J Med. 2007 May;65(5):188-90.

10.

Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections.

den Hollander JG, van Arkel C, Rijnders BJ, Lugtenburg PJ, de Marie S, Levin MD.

J Antimicrob Chemother. 2006 Jun;57(6):1248-50. Epub 2006 Mar 23.

PMID:
16556632
11.

[Summary of the practice guideline 'The STD consultation' from the Dutch College of General Practitioners].

den Hollander JG, Götz HM.

Ned Tijdschr Geneeskd. 2005 Nov 26;149(48):2702; author reply 2702. Dutch. No abstract available.

PMID:
16358625
12.

Cystatin C and the risk of death.

Berghout A, Wulkan RW, den Hollander JG.

N Engl J Med. 2005 Aug 25;353(8):842-4; author reply 842-4. No abstract available.

PMID:
16120867
13.

A cluster of acute hepatitis C virus infection among men who have sex with men--results from contact tracing and public health implications.

Götz HM, van Doornum G, Niesters HG, den Hollander JG, Thio HB, de Zwart O.

AIDS. 2005 Jun 10;19(9):969-74.

PMID:
15905679
14.

Correlation between severity of thyroid dysfunction and renal function.

den Hollander JG, Wulkan RW, Mantel MJ, Berghout A.

Clin Endocrinol (Oxf). 2005 Apr;62(4):423-7.

PMID:
15807872
15.

Sexually transmitted reinfection with a new hepatitis C genotype during pegylated interferon and ribavirin therapy.

den Hollander JG, Rijnders BJ, van Doornum GJ, van der Ende ME.

AIDS. 2005 Mar 24;19(6):639-40. No abstract available.

PMID:
15802989
16.

[Sexual transmission of hepatitis C in homosexual men].

Ruys TA, den Hollander JG, Beld MG, van der Ende ME, van der Meer JT.

Ned Tijdschr Geneeskd. 2004 Nov 20;148(47):2309-12. Dutch.

PMID:
15587046
17.

Anorectal ulcer in HIV patients, don't forget lymphogranuloma venereum!

Den Hollander JG, Ossewaarde JM, de Marie S.

AIDS. 2004 Jul 2;18(10):1484-5. No abstract available.

PMID:
15199332
18.

Is cystatin C a marker of glomerular filtration rate in thyroid dysfunction?

den Hollander JG, Wulkan RW, Mantel MJ, Berghout A.

Clin Chem. 2003 Sep;49(9):1558-9. No abstract available.

19.

Liposome-enabled synergistic interaction of antimicrobial agents.

Schiffelers RM, Storm G, ten Kate MT, Stearne-Cullen LE, den Hollander JG, Verbrugh HA, Bakker-Woudenberg IA.

J Liposome Res. 2002 Feb-May;12(1-2):121-7.

PMID:
12604045
20.

Population pharmacokinetic analysis of nonlinear behavior of piperacillin during intermittent or continuous infusion in patients with cystic fibrosis.

Vinks AA, Den Hollander JG, Overbeek SE, Jelliffe RW, Mouton JW.

Antimicrob Agents Chemother. 2003 Feb;47(2):541-7.

21.
22.

In vivo synergistic interaction of liposome-coencapsulated gentamicin and ceftazidime.

Schiffelers RM, Storm G, ten Kate MT, Stearne-Cullen LE, den Hollander JG, Verbrugh HA, Bakker-Woudenberg IA.

J Pharmacol Exp Ther. 2001 Jul;298(1):369-75.

PMID:
11408564
23.

[Gentamicin dosing regimen for neonates: once daily].

Den Hollander JG, Mouton JW.

Ned Tijdschr Geneeskd. 1998 Jun 27;142(26):1520. Dutch. No abstract available.

PMID:
9752073
24.

Duration and clinical relevance of postantibiotic effect in relation to the dosing interval.

den Hollander JG, Fuursted K, Verbrugh HA, Mouton JW.

Antimicrob Agents Chemother. 1998 Apr;42(4):749-54.

25.
26.

Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo.

den Hollander JG, Knudsen JD, Mouton JW, Fuursted K, Frimodt-Møller N, Verbrugh HA, Espersen F.

Antimicrob Agents Chemother. 1998 Feb;42(2):377-82.

27.

In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis.

Mouton JW, Endtz HP, den Hollander JG, van den Braak N, Verbrugh HA.

J Antimicrob Chemother. 1997 May;39 Suppl A:75-80.

PMID:
9511068
28.
29.

Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model.

den Hollander JG, Horrevorts AM, van Goor ML, Verbrugh HA, Mouton JW.

Antimicrob Agents Chemother. 1997 Jan;41(1):95-100.

30.

Alteration of postantibiotic effect during one dosing interval of tobramycin, simulated in an in vitro pharmacokinetic model.

den Hollander JG, Mouton JW, van Goor MP, Vleggaar FP, Verbrugh HA.

Antimicrob Agents Chemother. 1996 Mar;40(3):784-6.

31.

Enzymatic method for inactivation of aminoglycosides during measurement of postantibiotic effect.

den Hollander JG, Mouton JW, Bakker-Woudenberg IA, Vleggaar FP, van Goor MP, Verbrugh HA.

Antimicrob Agents Chemother. 1996 Feb;40(2):488-90.

32.
33.

Emergence of antibiotic resistance amongst Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Mouton JW, den Hollander JG, Horrevorts AM.

J Antimicrob Chemother. 1993 Jun;31(6):919-26.

PMID:
8360129

Supplemental Content

Loading ...
Support Center